Frank J Fokta

Title: Frank J Fokta: Innovator in Immunology

Introduction

Frank J Fokta is a notable inventor based in West Chicago, IL (US). He has made significant contributions to the field of immunology, particularly in the development of therapies for inflammatory and autoimmune diseases. With a total of 3 patents to his name, Fokta's work is recognized for its potential impact on medical treatments.

Latest Patents

Fokta's latest patents focus on innovative methods for selective inhibition of T-cell responses. One of his key inventions provides compositions, methods, and assays for treating inflammatory and autoimmune diseases, as well as for preventing transplanted tissue rejection. This invention utilizes anti-αβ TCR antibodies and antibody fragments, which are designed to bind to αβ TCR. Additionally, the patent outlines methods for treating these conditions using therapeutic dosing regimens of these antibodies and for upregulating the numbers of regulatory T-cells (Treg).

Career Highlights

Fokta is currently associated with Tolera Therapeutics, Inc., where he continues to advance his research and innovations. His work is pivotal in developing therapies that could significantly improve patient outcomes in the realm of immunological disorders.

Collaborations

Fokta collaborates with esteemed colleagues such as Daniel R Getts and James J Herrmann. Their combined expertise enhances the research and development efforts at Tolera Therapeutics, Inc.

Conclusion

Frank J Fokta's contributions to immunology through his patents and collaborations highlight his role as an influential inventor in the medical field. His work promises to pave the way for new therapeutic approaches to complex diseases.